ARCHIVES

NSABP Disputed NCI Cost Estimate For P-4 Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

New Publication Describes End-of-Life Care Projects

August 29, 2003

Clinical Education Guidelines Proposed

April 4, 1975

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says

May 7, 1999